A phase I study of foretinib plus erlotinib in patients with previously treated advanced non-small cell lung cancer: Canadian cancer trials group IND.196
Natasha B. Leighl(Robarts Clinical Trials), Penelope A. Bradbury(Robarts Clinical Trials)
Cited by 29
Related Papers
An Arm and a Leg: The Rising Cost of Cancer Drugs and Impact on Access
|American Society of Clinical Oncology Educational Book|2021|167